Combination of radio waves with pharmacologically active substances
AssigneesJochen Kalbe, Georg Ludwig
InventorsJochen Kalbe, Georg Ludwig
Life of this patent
Estimating the term…
Abstract
The invention relates to a combination of radio waves with pharmacologically active substances chosen from the group: a) monoclonal antibodies and/or b) tyrosine-kinase inhibitors and/or c) angiogenesis inhibitors and/or d) farnesyl-transferase inhibitors and/or e) topoisomerase-I or -II inhibitors and/or f) cytokines and/or g) antisense oligonucleotides. optionally together with one or more chemotherapeutics, as well as to the use of this combination for the prophylaxis and/or treatment of cancer, tumors and metastases.
Claims20
Combination of radio waves with at least one active agent chosen from the group comprising
- a) monoclonal antibodies and/or
- b) tyrosine-kinase inhibitors and/or
- c) angiogenesis inhibitors and/or
- d) farnesyl-transferase inhibitors and/or
- e) topoisomerase-I or -II inhibitors and/or
- f) cytokines and/or
- g) antisense oligonucleotides.
Use of radio waves with at least one active agent chosen from the group
- a) monoclonal antibodies and/or
- b) tyrosine-kinase inhibitors and/or
- c) angiogenesis inhibitors and/or
- d) farnesyl-transferase inhibitors and/or
- e) topoisomerase-I or -II inhibitors and/or
- f) cytokines and/or
- g) antisense oligonucleotides
- for providing a combination for the prophylaxis and/or treatment of cancer, carcinogenic and/or benign tumors and metastases.
Use of radio waves for increasing the activity of an active agent chosen from the group comprising
- a) monoclonal antibodies and/or
- b) tyrosine-kinase inhibitors and/or
- c) angiogenesis inhibitors and/or
- d) farnesyl-transferase inhibitors and/or
- e) topoisomerase-I or -II inhibitors and/or
- f) cytokines and/or
- g) antisense oligonucleotides and/or
- h) chemotherapeutics.
Use of radio waves for reducing the side effects of chemotherapeutics.
Dependencies are inferred from the claim text.